Sleep and Glycemic Control in Type 2 Diabetes Adolescents

This study is looking at how sleep affects blood sugar control in teenagers (ages 12-20) with Type 2 Diabetes (T2DM). The researchers want to see if there's a link between how much sleep you get and your blood sugar levels, measured by hemoglobin A1c (a long-term blood sugar test). They are also testing an intervention called a "loss frame sleep extension intervention" using Fitbit and text messages to help participants sleep more. The goal is to see if increasing sleep can improve blood sugar control. The study aims to enroll 90 participants and is currently unclear on its recruitment status.

Study design
This study involves different parts, including a cross-sectional design for 67 participants and an interventional design for 15 participants. It is not specified if it is randomized or blinded.
What's involved
Participants will wear an actigraphy watch for 14 days and a Libre continuous glucose monitor (CGM). Some participants will also use a Fitbit and receive text messages as part of the sleep intervention.
Compensation
Not stated in the trial record.
Follow-up
Sleep duration will be measured at 13 weeks for one part of the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04213547

Sleep and Glycemic Control in Type 2 Diabetes Adolescents

Recruiting
NAAges 12–20InterventionalSupportive care
Children's Hospital of Philadelphia
~90 participants
Updated 2026-06-29 on ClinicalTrials.gov
What's tested:Loss frame sleep extension intervention

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Sleep duration (for Aim 2)
Measured over 13 weeks
+3 more outcomes measured
Type 2 Diabetes
1 sites across 1 states
Pennsylvania1
  • Talia A Hitt, MD/MPH · STUDY_DIRECTOR · Children's Hospital of Philadelphia

Opens a ready-to-send draft in your own email app — review before sending.

  • Sleep duration (for Aim 2)13 weeks

    Will assess for sleep extension throughout intervention

  • Hemoglobin A1c (for Aim 1)baseline

    Aim 1 is assessing cross-sectional relationship of A1c to sleep duration

  • BMI (for Aim 1)baseline

    Aim 1 is assessing cross-sectional relationship of BMI to sleep duration

  • Qualitative data from focus groupbaseline at focus group

    Qualitative output from focus group discussion on text messages